شیرین دارو
دشیری | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Income Statement
AGM
Interim
2026/06/16 Fiscal Year 2026/03/2012 Month | 2025/04/30 Fiscal Year 2025/03/2012 Month | 2024/07/14 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 4.142 Trillion | 2.953 Trillion | 1.603 Trillion | |
Total Revenues | 4.142 Trillion | 2.953 Trillion | 1.603 Trillion | |
Cost of Goods Sold | 1.86 Trillion | 1.659 Trillion | 1.017 Trillion | |
Gross Profit | 2.282 Trillion | 1.294 Trillion | 586.175 Billion | |
General & Administrative Expenses | 319.826 Billion | 214.258 Billion | 164.516 Billion | |
Net Operating Income & Expenses | 570.296 Billion | 336.175 Billion | 595.183 Billion | |
Operating Profit (Loss) | 2.532 Trillion | 1.416 Trillion | 1.017 Trillion | |
Profit Before Tax | 2.546 Trillion | 1.606 Trillion | 1.028 Trillion | |
Tax | 3.602 Billion | 6.687 Billion | 848 Million | |
Net Profit (Loss) After Tax | 2.543 Trillion | 1.599 Trillion | 1.027 Trillion | |
Retained Earnings at Beginning of Period | 2.2 Trillion | 1.321 Trillion | 575.65 Billion | |
Approved Dividends — Prior Year AGM | -1.76 Trillion | -720 Billion | -287.85 Billion | |
Transfer from Other Equity Items | - | -21 Million | 6.175 Billion | |
Allocable Profit | 2.983 Trillion | 2.2 Trillion | 1.321 Trillion | |
Approved Dividends — Current Year | 2 Trillion | 1.76 Trillion | 720 Billion | |
Retained Earnings at End of Period | 983.165 Billion | 440.474 Billion | 601.472 Billion |